Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-7733

CMS347 Statin Therapy

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Ashley Porcello
    • 5027187298
    • Hide
      Thank you for reaching out with your question regarding CMS347v8. The guidance section in the header in the measure specification outlines a process to prevent counting patients in more than one of the four populations. When implementing this measure, if you were unable to identify patients for Initial Population 4 but are implementing the measure as specified, it could mean that either no patients meet the criteria for Initial Population 4 or that all patients were captured in Initial Populations 1-3. For reference, I have included the guidance for each Initial Population that is published in the measure header:
       
      Initial Population Guidance:
      The initial population covers four distinct populations. Use the following process to prevent counting patients more than once.
       
      Initial Population 1:
      All patients who were previously diagnosed with or currently have a diagnosis of clinical ASCVD, including an ASCVD procedure before the end of the measurement period.
       
      - If YES, meets Initial Population 1 risk category.
      - If NO, screen for next risk category.
       
      Initial Population 2:
      Patients aged 20 to 75 years at the beginning of the measurement period who have ever had a laboratory test result of LDL-C >= 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia.
       
      - If YES, meets Initial Population 2 risk category.
      - If NO, screen for next risk category.
       
      Initial Population 3:
      Patients aged 40 to 75 years at the beginning of the measurement period with an active diagnosis of Type 1 or Type 2 diabetes at any time during the measurement period.
       
      - If YES, meets Initial Population 3 risk category.
      - If NO, screen for next risk category.
       
      Initial Population 4:
      Patients aged 40 to 75 at the beginning of the measurement period with a 10-year ASCVD risk score of >= 20 percent during the measurement period.
       
      - If YES, meets Initial Population 4 risk category.
      - If NO, patient does NOT meet Initial Population criteria and is NOT eligible for measure inclusion.
       
      Initial Population Guidance for Encounter:
      In order for the patient to be included in the Initial Population, the patient must have ONE initial population-eligible visit, defined as follows: outpatient visit, initial or established office visit, face-to-face interaction, preventive care services, or annual wellness visit.
       
      LDL-C Laboratory test result options:
      The measure can be reported for all patients with a documented LDL-C level recorded as follows:
       
      To meet Initial Population 1:
      There is no LDL-C result required.
       
      To meet Initial Population 2:
      If a patient has ANY previous laboratory result of LDL-C >= 190 mg/dL, report the highest value >= 190 mg/dL.
       
      To meet Initial Population 3:
      There is no LDL-C result required.
       
      To meet Initial Population 4:
      There is no LDL-C result required.
       
      The 10-year ASCVD risk assessment options:
      The 10-year ASCVD risk score is calculated using the Pooled Cohort Equations: 1) the 2013 ACC/AHA ASCVD Risk Estimator (maps to LOINC Code 79423-0) OR 2) the ACC Risk Estimator Plus (maps to LOINC Code 99055-6). If your EHR does not have either of these risk calculators, we recommend that you use the on-line versions. The 10-year ASCVD risk score (quantitative result, i.e., result.value, "%") must be documented in a structured field. The 10-year ASCVD risk assessment must be performed during the measurement period.
      Show
      Thank you for reaching out with your question regarding CMS347v8. The guidance section in the header in the measure specification outlines a process to prevent counting patients in more than one of the four populations. When implementing this measure, if you were unable to identify patients for Initial Population 4 but are implementing the measure as specified, it could mean that either no patients meet the criteria for Initial Population 4 or that all patients were captured in Initial Populations 1-3. For reference, I have included the guidance for each Initial Population that is published in the measure header:   Initial Population Guidance: The initial population covers four distinct populations. Use the following process to prevent counting patients more than once.   Initial Population 1: All patients who were previously diagnosed with or currently have a diagnosis of clinical ASCVD, including an ASCVD procedure before the end of the measurement period.   - If YES, meets Initial Population 1 risk category. - If NO, screen for next risk category.   Initial Population 2: Patients aged 20 to 75 years at the beginning of the measurement period who have ever had a laboratory test result of LDL-C >= 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia.   - If YES, meets Initial Population 2 risk category. - If NO, screen for next risk category.   Initial Population 3: Patients aged 40 to 75 years at the beginning of the measurement period with an active diagnosis of Type 1 or Type 2 diabetes at any time during the measurement period.   - If YES, meets Initial Population 3 risk category. - If NO, screen for next risk category.   Initial Population 4: Patients aged 40 to 75 at the beginning of the measurement period with a 10-year ASCVD risk score of >= 20 percent during the measurement period.   - If YES, meets Initial Population 4 risk category. - If NO, patient does NOT meet Initial Population criteria and is NOT eligible for measure inclusion.   Initial Population Guidance for Encounter: In order for the patient to be included in the Initial Population, the patient must have ONE initial population-eligible visit, defined as follows: outpatient visit, initial or established office visit, face-to-face interaction, preventive care services, or annual wellness visit.   LDL-C Laboratory test result options: The measure can be reported for all patients with a documented LDL-C level recorded as follows:   To meet Initial Population 1: There is no LDL-C result required.   To meet Initial Population 2: If a patient has ANY previous laboratory result of LDL-C >= 190 mg/dL, report the highest value >= 190 mg/dL.   To meet Initial Population 3: There is no LDL-C result required.   To meet Initial Population 4: There is no LDL-C result required.   The 10-year ASCVD risk assessment options: The 10-year ASCVD risk score is calculated using the Pooled Cohort Equations: 1) the 2013 ACC/AHA ASCVD Risk Estimator (maps to LOINC Code 79423-0) OR 2) the ACC Risk Estimator Plus (maps to LOINC Code 99055-6). If your EHR does not have either of these risk calculators, we recommend that you use the on-line versions. The 10-year ASCVD risk score (quantitative result, i.e., result.value, "%") must be documented in a structured field. The 10-year ASCVD risk assessment must be performed during the measurement period.
    • CMS0347v8
    • CMS0347v7
    • no numerator or denominator pop 4

      all populations 1,2,3 have data. population 4 we do not. does this matter?

            AIR EC eCQM Team AIR EC eCQM Team
            aporcello Ashley Porcello
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: